Consistent effects of genes involved in reverse cholesterol transport on plasma lipid and apolipoprotein levels in CARDIA participants

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 8, 2006, Pages 1828-1836

  Klos, Kathy L E ^a,f   Sing, Charles F ^b   Boerwinkle, Eric ^a,c   Hamon, Sara C ^d   Rea, Thomas J ^b   Clark, Andrew ^e   Fornage, Myriam ^c   Hixson, James E ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

^e Department of Obstetrics Gynecology   (United States)

^f UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Genetics of cardiovascular disease; Lipid and lipoprotein metabolism; Lipids

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN A5; APOLIPOPROTEIN B; APOLIPOPROTEIN C1; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN C4; APOLIPOPROTEIN E; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ESTER TRANSFER PROTEIN; GENE PRODUCT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN LPL; PROTEIN SOAT1; PROTEIN SREBF2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ABC TRANSPORTER; APOLIPOPROTEIN A; APOLIPOPROTEIN C; CARRIER PROTEIN; CETP PROTEIN, HUMAN; CHOLESTEROL; GLYCOPROTEIN;

ADULT; ARTICLE; CAUCASIAN; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; MOLECULAR GENETICS; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; ACTIVE TRANSPORT; BLOOD; CORONARY ARTERY ATHEROSCLEROSIS; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; METABOLISM;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; APOLIPOPROTEINS; APOLIPOPROTEINS A; APOLIPOPROTEINS C; APOLIPOPROTEINS E; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT, ACTIVE; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CORONARY ARTERIOSCLEROSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLYCOPROTEINS; HAPLOTYPES; HUMANS; LIPIDS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33746847377     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000231523.19199.45     Document Type: Article

References (65)

1. Am Heart Association. Heart Disease and Stroke Statistics - 2005 update. Dallas, Tex. 2005
2. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81:7B-12B
3. Castelli WP, Anderson K, Wilson PW, Levy D. Lipids and risk of coronary heart disease: The Framingham Study. Ann Epidemiol. 1992;2:23-28.
4. Gordon DJ, Rifkind BM. High-density lipoprotein: the clinical implications of recent studies. N England J Med. 1989;321:1311-1316.
5. Davignon J, Cohn JS. Triglycerides: a risk factor for coronary heart disease. Atherosclerosis. 1996;124:S57-S64.
6. Miller GJ, Miller NE. Plasma-high-density-lipoprotein concentration and development of ischemic heart disease. Lancet. 1975;1:16-19.
7. Brunzell JD, Sniderman AD, Albers JJ, Kwiterovich PO Jr. apolipoproteins B and A-I and coronary artery disease in humans. Arterioscler. 1984;4:79-83.
8. Kottke BA, Holmes DR, Mao SJT, Kneller RW, Hallaway BJ, Zinsmeister AR. apolipoproteins and coronary heart disease. Circulation. 1985;71:415A
9. Lusis AJ. Athersoclerosis Nature. 2000;407:233-237.
10. Sing CF, Stengard JH, Kardia SL. Genes, environment and coronary artery disease Atherosler Thromb Vasc Biol. 2003;23:1190-1196.
11. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res. 1995;36:211-228.
12. von Eckardstein A, Nofer J-R, Assmann G. High density lipoproteins and arteriosclerosis: Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol. 2001;21:13-27.
13. Rea TJ, Brown CM, Sing CF. Complex adaptive system models and the genetic analysis of plasma HDL-cholesterol levels. Perspectives Biol Med. 2006;in press.
14. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nature Rev Genet. 2005;6:95-108.
15. Reilly SL, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN I Pleiotropic effects on means and variances. Am J Hum Genet. 1991;49:1155-1166.
16. Lussier-Cacan S, Bolduc A, Xhignesse M, Nioysenga T, Connely PW, Sing CF. Impact of age and body size on inter-individual variation in measures of lipid metabolism: Influence of gender and apolipoprotein E genotype. Clin Genet. 2000;57:35-47.
17. Hughes GH, Cutter G, Donahue R, Friedman GD, Hulley S, Hunkeler E, Jacobs DR Jr., Liu K, Orden S, Pirie P, Tucker B, Wagenknecht LE. Recruitment in the Coronary Artery Disease Risk Development in Young Adults (Cardia) Study. Control Clin Trials. 1987;8(4 Suppl):68S-73S.
18. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR Jr., Liu K, Savage PJ. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41:1105-1116.
19. Warnick GR. Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol. 1986;129:101-123.
20. Warnick GR, Benderson J, Albers JJ. Dextran sulphate -Mg+ precipitation procedure for quantification of high density lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.
21. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma. Clin Chem. 1972;18:499-501.
22. Albers JJ, Adolphson JL. Comparison of commercial kits for apolipoprotein A-I and apolipoprotein B with standardized apolipoprotein A-I and B radioimmunoassay performed at the Northwest Lipid Research Center. J Lipid Res. 1988;29:102-108.
23. Sokal RR, Rohlf FJ. Biometry: the principles and practice of statistics in biological research. New York, NY: Freeman and Company; 1998.
24. Levene H. Robust tests for equality of variance. Contributions to probability and statistics. Stanford, CA: Stanford University Press; 1960.
25. Welch BL. On the comparison of several mean values: an alternative approach. Biometrika. 1951;38:330-336.
26. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol. 1995;12:921-927.
27. Fallin D, Schork NJ. Accuracy of haplotype frequency estimation for bialleleic loci, via the expectation-maximization algorithm for un-phased diploid genotype data. Am J Hum Genet. 2000;67:947-959.
28. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered. 2001;53:79 -91.
29. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc. 1995;B57:289-300.
30. Schmitz G, Kaminski WE, Orso E. ABC transporters in cellular lipid trafficking. Curr Opin Lipidol. 2000;11:493-501.
31. Schmitz G, Langmann T. Structure, function and regulation of the ABC1 gene product. Curr Opin Lipidol. 2001;12:129-140.
32. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, Tybjærg-Hansen A. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest. 2004;114:1343-1353.
33. Clee SM, Zwinderman AH, Enghert JC, Zwarts KY, Molhuizen HOF, Roomp K, Jukema W, van Wijland M, vanDam M, Hudson TJ, Brooks-Wilson A, Genest J Jr, Kastelein JJP, Hayden M. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation. 2001;103:1198-1205.
34. Lai C-Q, Parnell LD, Ordovas JM. The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk. Curr Opin Lipidol. 2005;16:153-166.
35. Klos KL, Hamon S, Clark AG, Boerwinkle E, Liu K, Sing CF. APOA5 polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study. J Lipid Res. 2005;46:564-571.
36. Gibbons GH, Liew CC, Goodarzi MO, Rotter JI, Hsueh WA, Siragy HM, Pratt R, Dzau VJ. Genetic markers. Progress and potential for cardiovascular disease. Circulation. 2004;109:IV47-IV58.
37. Jeenah M, Kessling A, Miller N, Humphries S. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med. 1990;7:233-241.
38. Kamboh MI, Bunker CH, Aston CE, Nestlerode CS, McAllister AE, Ukoli FA. Genetic association of five apolipoprotein polymorphisms with serum lipoprotein-lipid levels in African blacks. Genet Epidemiol. 1999;16:205-222.
39. Russo GT, Meigs JB, Cupples LA, Demissie S, Otvos JD, Wilson PWF, Lahoz C, Cucinotta D, Couture P, Mallory T, Schaefer EJ, Ordovas JM. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis. 2001;158:173-181.
40. Li G-P, Wang J-Y, Yan B-S, Xue H, Wu G. Genetic effect of two polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene on serum lipids and lipoproteins levels in a Chinese population. Clin Genet. 2004;65:470-476.
41. Hagberg JM, Wilund KR, Ferrell RE. APOE gene and gene-environment effects on plasma lipoprotein-lipid levels. Physiol Genomics. 2000;4:101-108.
42. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002;6:487-495.
43. Ribalta J, VallvéJ-C, Girona J, Masana L. apolipoprotein and apolipoprotein receptor genes, blood lipids and disease. Curr Opin Clin Nutr Metab Care. 2003;6:177-187.
44. Stengård JH, Clark AG, Weiss KM, Kardia S, Nickerson DA, Salomaa V, Ehnholm C, Boerwinkle E, Sing CF. Contributions of 18 additional DNA sequence variations in the gene for apolipoprotein E to explaining variation in quantitative measures of lipid metabolism. Am J Hum Genet. 2002;71:501-517.
45. Boekholdt SM, Thompson JF. Natural variation as a tool in understanding the role of CETP in lipid levels and disease. J Lip Res. 2003;44:1080-1093.
46. Klerkx AHEM, Tanck MWT, Kastelein JJP, Molhuizen HOF, Jukema JW, Zwinderman AH, Kuivenhoven JA. Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C>A polymorphism and a novel promoter variant are independently associated with CETP concentration. Hum Mol Genet. 2003;12:111-123.
47. Thompson JF, Lira ME, Durham LK, Clark RW, Bamberger MJ, Milos PM. Polymorphisms in the CETP gene and association with CETP mass and HDL levels. Atherosclerosis. 2003;167:195-204.
48. Biegneux A, Hofmann AF, Young SG. Human CYP7A1 deficiency: progress and enigmas. J Clin Invest. 2002;110:109-117.
49. Wang J, Freeman DJ, Grundy SM, Levine DM, Guerra R, Cohen JC. Linkage between cholesterol 7a-hydroxylase and high plasma lowdensity lipoprotein cholesterol concentrations. J Clin Invest. 1998;101:1283-1291.
50. Lin JP, Myers RH, Almasy L, Coon HH, Arnett DK, Hong Y, Hunt SC. Linkage of the cholesterol 7-alpha-hydroxylase gene and low-density lipoprotein cholesterol conditional on apolipoprotein E association: the National Heart, Lung, and Blood Institute Family Heart Study Chin Med J. 2005;118:362-369.
51. Hofman MK, Groenendijk M, Verkuijlen PJJH, Jonkers IJAM, Mohrschladt MF, Smelt AHM, Princen HMG. Modulating effect of the A-278C promoter polymorphism in the cholesterol 7alph-hydroxylase gene on serum lipid levels in normolipidaemic and hypertriglyceridaemic individuals. Eur J Hum Genet. 2004;12:935-941.
52. Zhou B, Zhang SZ, Xiao CY, Zhang L, Li GX, Liu HK, Zheng KQ. [Association of 7alpha-hydroxylase gene polymorphism with levels of plasma lipids]. Yi Chuan. 2004;26:283-286.
53. Han Z, Heath SC, Shmulewitz D, Li W, Auerbach SB, Blundell ML, Lehner T, Ott J, Stoffel M, Friedman JM, Breslow JL. Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia. Am J Med Genet. 2002;110:234-242.
54. Stein Y, Stein O. Lipoprotein lipase and atherosclerosis. Atherosclerosis. 2003;170:1-9.
55. Merkel M, Eckel RH, Goldberg IJ. Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res. 2002;43:1997-2006.
56. Talmud PJ, Stephens JW. Lipoprotein lipase gene variants and the effect of environmental factors on cardiovascular disease risk. Diabetes Obesity Metab. 2004;6:1-7.
57. Nickerson DA, Taylor SL, Weiss KM, Clark AG, Hutchinson RG, Stengård J, Salomaa V, Vartiainen E, Boerwinkle E, Sing CF. SNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nature Genet. 1998;19:233-240.
58. Templeton AR, Clark AG, Weiss KM, Nickerson DA, Boerwinkle E, Sing CF. Recombinational and mutational hotspots within the human lipoprotein lipase gene. Am J Hum Genet. 2000;66:69-83.
59. Lee C-H, Olson P, Evans RM. Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology. 2003;144:2201-2207.
60. Chan E, Tan CS, Deurenberg-Yap M, Chia KS, Chew SK, Tai ES. The C227A polymorphism at the PPARA locus is associated with serum lipid concentrations and modulates the association between dietary polyunsaturated fatty acid intake and serum high density lipoprotein concentrations in Chinese women. Atherosclerosis. 2005; November 7. Epub Ahead of Print.
61. Liscum L, Underwood KW. Intracellular cholesterol transport and compartmentalization. J Biol Chem. 1995;270:15443-15446.
62. Hegele RA. Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism. Am J Hum Genet. 69:1161-1177.
63. Eberlé D, Hegarty B, Bossard P, Ferré P, Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie. 2004;86:839-848.
64. Miserez AR, Muller PY, Barella L, Barella S, Staehelin HB, Leitersdorf E, Kark JD, Friedlander Y. Sterol-regulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterolaemia. Atherosclerosis. 2002;164:15-26.
65. Duan X, Zhu W, Yin X, Dao J. [Relations between polymorphism of sterol regulatory element binding protein-2 gene and hyperlipidemia in the Han ethics of China]. Wei Sheng Yan Jiu. 2004;33:314-316.